Breaking News Instant updates and real-time market news.

MYL

Mylan

$35.19

3.83 (12.21%)

, BKNG

Booking Holdings

$1,992.40

110.5 (5.87%)

09:55
11/06/18
11/06
09:55
11/06/18
09:55

Early notable gainers among liquid option names on November 6th

Notable gainers among liquid option names this morning include Mylan (MYL) $35.19 +3.78, Booking Holdings (BKNG) $2004.00 +131.00, Occidental Petroleum (OXY) $73.48 +3.48, Mosaic (MOS) $33.72 +1.49, and Martin Marietta (MLM) $181.90 +7.30.

MYL

Mylan

$35.19

3.83 (12.21%)

BKNG

Booking Holdings

$1,992.40

110.5 (5.87%)

OXY

Occidental Petroleum

$72.98

2.84 (4.05%)

MOS

Mosaic

$33.63

1.39 (4.31%)

MLM

Martin Marietta

$180.00

5.19 (2.97%)

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

MYL Mylan
$35.19

3.83 (12.21%)

11/06/18
COWN
11/06/18
NO CHANGE
Target $31
COWN
Market Perform
Mylan business model looks broken, says Cowen
Cowen analyst Ken Cacciatore said Mylan's Q3 results confirm his thesis that the current business model looks broken. He said at some point a new product cycle needs to materialize, but in Mylan's case it hasn't happened in a material enough way. Cacciatore recommends avoiding the shares and he reiterated his Market Perform rating and $31 price target on Mylan.
11/06/18
BOFA
11/06/18
UPGRADE
BOFA
Buy
Mylan upgraded to Buy from Neutral at BofA/Merrill
11/06/18
11/06/18
UPGRADE
Target $42

Buy
Mylan upgraded to Buy after 'encouraging' Q3 report at BofA/Merrill
As previously reported, BofA Merrill Lynch analyst Jason Gerberry upgraded Mylan to Buy from Neutral, stating that its Q3 report provided encouraging updates regarding several of its business segments. He believes concerns around its broader portfolio look overdone as industry-level generic pricing is showing signs of stabilizing while the company also provided encouraging new product updates. Gerberry added that he views the 20% stock pullback as an attractive opportunity, but trimmed his price target on Mylan shares to $42 from $44 to reflect rebasing of EpiPen and generic Copaxone.
11/06/18
MZHO
11/06/18
NO CHANGE
Target $39
MZHO
Neutral
Mylan target raised to $39 on 'comforting' Q3 results at Mizuho
Mylan reported "comforting" Q3 results with $300M in high margin new product sales and reiterated its 2018 guidance, Mizuho analyst Irina Koffler tells investors in a post-earnings research note. The analyst raised her price target for the shares to $39 from $37 and reiterates a Neutral rating on the name.
BKNG Booking Holdings
$1,992.40

110.5 (5.87%)

11/06/18
MSCO
11/06/18
NO CHANGE
Target $2100
MSCO
Overweight
Booking Q3 results, Q4 outlook illustrate 'multiple levers,' says Morgan Stanley
Morgan Stanley analyst Brian Nowak said Booking Holdings' Q3 room nights growth being 200bp better than expected and its Q4 guidance, with the top end of room nights growth being 100bp better than expected, speak to the multiple levers the company has to pull. He is particularly bullish about the percentage of room nights coming from direct channels increasing year-over-year and the fact that direct traffic remains the largest source of new customer growth. Nowak keeps an Overweight rating and $2,100 price target on Booking shares.
11/06/18
DADA
11/06/18
NO CHANGE
Target $2000
DADA
Neutral
Booking Holdings price target nudged higher to $2,000 at DA Davidson
DA Davidson analyst Tome White raised his price target on Booking Holdings to $2,000 from $1,980 after its "strong" Q3 top-line beat and a 1% EBITDA upside, saying the 12% growth in gross bookings was also above his 5% estimate. The analyst notes however that the performance was also supported by the "later summer peak travel and higher growth from paid marketing channels," adding that the management is also prepared to "tolerate margin compression" to achieve above-industry growth rate in 2019. White also keeps his Neutral rating on Booking Holdings, noting its 20-times forward earnings valuation multiple.
11/06/18
FBCO
11/06/18
NO CHANGE
Target $2240
FBCO
Outperform
Booking Holdings price target raised to $2,240 from $2,100 at Credit Suisse
Credit Suisse analyst Stephen Ju raised his price target for Booking Holdings to $2,240 from $2,100 following quarterly results. The analyst reiterates an Outperform rating on the shares.
11/06/18
SUSQ
11/06/18
NO CHANGE
Target $2300
SUSQ
Positive
Booking Holdings price target raised to $2,300 from $2,200 at Susquehanna
Susquehanna analyst Shyam Patil raised his price target on Booking Holdings to $2,300 from $2,200 following its Q3 results. The analyst likes its secular opportunity to penetrate hotels and alternative accommodations room nights. He believes the room night growth acceleration will ease fears around perpetual growth deceleration. Patil reiterated his Positive rating on Booking Holdings shares.
OXY Occidental Petroleum
$72.98

2.84 (4.05%)

10/15/18
MUFG
10/15/18
NO CHANGE
Target $92
MUFG
Neutral
Occidental Petroleum price target lowered to $92 from $97 at MUFG
MUFG analyst Michael McAllister lowered his price target on Occidental Petroleum to $92 and kept his Neutral rating after the company disclosed that it will stop operating the Idd El-Shargi field. The analyst also lowers his 2020 total production estimate by 2.5% to 768K MBOE per day to reflect the loss, even though Occidental Petroleum believes that it can make up the lost output by allocating the field's capital to other programs in its portfolio. Shares of Occidental Petroleum were down over 6% today on the news.
09/27/18
PIPR
09/27/18
INITIATION
PIPR
Overweight
Occidental Petroleum assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Ryan Todd assumed coverage of Occidental Petroleum with an Overweight rating and a $90 price target.
10/22/18
RAJA
10/22/18
UPGRADE
RAJA
Strong Buy
Occidental Petroleum upgraded to Strong Buy from Outperform at Raymond James
10/22/18
10/22/18
UPGRADE
Target $90

Strong Buy
Occidental Petroleum upgraded to Strong Buy on valuation at Raymond James
As previously reported, Raymond James upgraded Occidental Petroleum to Strong Buy from Outperform with a $90 price target. Analyst Pavel Molchanov said Occidental shares are down 2% year-to-date versus the E&P index's 8% gain, and the dividend yield now stands at 4.3%. The analyst believes this is an opportunistic time to upgrade shares given the firm's newly increased oil forecast.
MOS Mosaic
$33.63

1.39 (4.31%)

10/10/18
SBSH
10/10/18
UPGRADE
SBSH
Buy
Mosaic upgraded to Buy from Neutral at Citi
09/04/18
LEHM
09/04/18
INITIATION
Target $34
LEHM
Equal Weight
Mosaic initiated with an Equal Weight at Barclays
Barclays analyst Duffy Fischer started Mosaic with an Equal Weight rating and $34 price target. The recent rally in fertilizer stocks assumes constructive market conditions will extend beyond the second half of 2018, which is less than certain, Fischer tells investors in a research note. The analyst worries that delayed new capacity is still coming and will stall the price recovery.
10/10/18
SBSH
10/10/18
UPGRADE
Target $40
SBSH
Buy
Citi upgrades Mosaic to Buy amid 'more favorable' phosphate demand
Citi analyst P.J. Juvekar upgraded Mosaic to Buy from Neutral and raised his price target for the shares to $40 from $36. The analyst believes phosphate supply and demand is "looking more favorable" and that fertilizer prices were strong in Q3. Prices don't need to rise much to justify a Buy rating on Moasic, Juvekar tells investors in a research note. Further, he believes phosphate prices could benefit from potential environmental restrictions in China.
10/02/18
RBCM
10/02/18
NO CHANGE
Target $40
RBCM
Outperform
Mosaic price target raised to $40 from $36 at RBC Capital
RBC Capital analyst Andrew Wong raised his price target on Mosaic to $40 and kept his Outperform rating, saying the company stands to benefit from a tightening phosphates balance because of a "lack of new capacity". The analyst also cites a "balanced potash market supported by strong shipments" as well as "constructive" agriculture fundamentals in Brazil, anticipating the stock to re-rate higher and close its valuation gap with its peer group. Wong contends that Mosaic represents an "ideal investment" in the agricultural commodity upside scenario.
MLM Martin Marietta
$180.00

5.19 (2.97%)

10/29/18
NOMU
10/29/18
INITIATION
Target $220
NOMU
Buy
Martin Marietta initiated with a Buy at Nomura Instinet
Nomura Instinet analyst Michael Wood started Martin Marietta with a Buy rating and $220 price target. The analyst prefers Martin Marietta in the aggregates industry based on improving spending in Texas, which he believes will drive better pricing power and resulting margin leverage. He sees 36% potential upside from current share levels.
10/17/18
BOFA
10/17/18
DOWNGRADE
Target $179
BOFA
Neutral
Martin Marietta downgraded to Neutral at BofA/Merrill
As previously reported, BofA/Merrill downgraded Martin Marietta to Neutral from Buy and cut its price target to $179 from 225. Analyst Timna Tanners thinks increased hurricane activity and unusually heavy rains have contributed to disappointing volumes and a lower multiple is more appropriate given lack of catalysts and concerns the US construction cycle is nearing a peak.
10/17/18
BOFA
10/17/18
DOWNGRADE
BOFA
Neutral
Martin Marietta downgraded to Neutral from Buy at BofA/Merrill
10/11/18
DADA
10/11/18
NO CHANGE
Target $200
DADA
Neutral
Martin Marietta price target lowered to $200 from $225 at DA Davidson
DA Davidson analyst Brent Thielman lowered his price target on Martin Marietta to $200 and kept his Neutral rating, also lowering his FY18 EPS view to $8.74 from $9.35 and FY19 view to $10.63 from $11.50. The analyst cites the "anticipated weather-related headwinds in the quarter", particularly in Texas and also the select Midwest/Mid-Atlantic markets. Thielman adds that along with the project delays in related territories and the increases in variable costs, his prior forecasts were likely "too optimistic".

TODAY'S FREE FLY STORIES

PFE

Pfizer

$42.41

0.45 (1.07%)

12:56
02/17/19
02/17
12:56
02/17/19
12:56
Hot Stocks
Pfizer, EMD Serono announce publication of Phase 3 data for BAVENCIO plus INLYTA »

Merck KGaA, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

MRK

Merck

$79.84

0.9 (1.14%)

, PFE

Pfizer

$42.41

0.45 (1.07%)

12:48
02/17/19
02/17
12:48
02/17/19
12:48
Hot Stocks
Merck presents results from Phase 3 KEYNOTE-426 study »

Merck (MRK) announced…

MRK

Merck

$79.84

0.9 (1.14%)

PFE

Pfizer

$42.41

0.45 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Apr

  • 18

    May

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

12:42
02/17/19
02/17
12:42
02/17/19
12:42
Hot Stocks
Aveo Pharmaceuticals presents TIVO-3 trial topline results »

Aveo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDM

Aradigm

$0.00

(0.00%)

12:34
02/17/19
02/17
12:34
02/17/19
12:34
Hot Stocks
Aradigm announces plans for reorganization under Chapter 11 »

Aradigm has filed for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.